Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 22

1.

The decreased metastatic potential of rhabdomyosarcoma cells obtained through MET receptor downregulation and the induction of differentiation.

Miekus K, Lukasiewicz E, Jarocha D, Sekula M, Drabik G, Majka M.

Cell Death Dis. 2013 Jan 17;4:e459. doi: 10.1038/cddis.2012.199.

2.

Synthesis of a major mitomycin C DNA adduct via a triaminomitosene.

Champeil E, Paz MM, Lukasiewicz E, Kong WS, Watson S, Sapse AM.

Bioorg Med Chem Lett. 2012 Dec 1;22(23):7198-200. doi: 10.1016/j.bmcl.2012.09.052. Epub 2012 Sep 25.

PMID:
23079525
3.

Effect of Traumeel S on cytokine profile in a cecal ligation and puncture (CLP) sepsis model in rats.

Oberbaum M, Spira RM, Lukasiewicz E, Armon Y, Samuels N, Singer SR, Barak V, Izbicki G, Einav S, Hersch M.

J Altern Complement Med. 2011 Oct;17(10):909-13. doi: 10.1089/acm.2011.0205. Epub 2011 Oct 6.

PMID:
21978221
4.

Report on the analysis of common beverages spiked with gamma-hydroxybutyric acid (GHB) and gamma-butyrolactone (GBL) using NMR and the PURGE solvent-suppression technique.

Lesar CT, Decatur J, Lukasiewicz E, Champeil E.

Forensic Sci Int. 2011 Oct 10;212(1-3):e40-5. doi: 10.1016/j.forsciint.2011.06.017. Epub 2011 Jul 20.

PMID:
21775083
5.

Differential expression of Snail1 transcription factor and Snail1-related genes in alveolar and embryonal rhabdomyosarcoma subtypes.

Püsküllüoglu M, Lukasiewicz E, Miekus K, Jarocha D, Majka M.

Folia Histochem Cytobiol. 2010 Dec;48(4):671-7. doi: 10.2478/v10042-010-0046-7.

6.

Traumeel S for pain relief following hallux valgus surgery: a randomized controlled trial.

Singer SR, Amit-Kohn M, Weiss S, Rosenblum J, Maoz G, Samuels N, Lukasiewicz E, Freedman L, Paltiel O, Itzchaki M, Niska M, Oberbaum M.

BMC Clin Pharmacol. 2010 Apr 12;10:9. doi: 10.1186/1472-6904-10-9.

7.

Combining longitudinal discriminant analysis and partial area under the ROC curve to predict non-response to treatment for hepatitis C virus.

Lukasiewicz E, Gorfine M, Neumann AU, Freedman LS.

Stat Methods Med Res. 2011 Jun;20(3):275-89. doi: 10.1177/0962280209341624. Epub 2010 Mar 3. Review.

PMID:
20200199
8.

Inhibition of rhabdomyosarcoma's metastatic behavior through downregulation of MET receptor signaling.

Lukasiewicz E, Miekus K, Kijowski J, Drabik G, Wilusz M, Bobis-Wozowicz S, Majka M.

Folia Histochem Cytobiol. 2009 Jan;47(3):485-9. doi: 10.2478/v10042-009-0108-x.

9.
10.

Prediction of nonSVR to therapy with pegylated interferon-alpha2a and ribavirin in chronic hepatitis C genotype 1 patients after 4, 8 and 12 weeks of treatment.

Lukasiewicz E, Gorfine M, Freedman LS, Pawlotsky JM, Schalm SW, Ferrari C, Zeuzem S, Neumann AU; DITTO-HCV Study Group.

J Viral Hepat. 2010 May;17(5):345-51. doi: 10.1111/j.1365-2893.2009.01183.x. Epub 2009 Sep 25.

PMID:
19780947
11.

[Angiogenesis in different clinical phases of chronic myeloid leukemia].

Krasowska-Kwiecień A, Kijowski J, Łukasiewicz E, Sacha T, Foryciarz K, Majka M, Ratajczak MZ, Skotnicki AB.

Przegl Lek. 2009;66(9):471-8. Polish.

PMID:
21033405
12.

Adventage of mesenchymal stem cells (MSC) expansion directly from purified bone marrow CD105+ and CD271+ cells.

Jarocha D, Lukasiewicz E, Majka M.

Folia Histochem Cytobiol. 2008;46(3):307-14. doi: 10.2478/v10042-008-0046-z.

13.

HCV-specific T-cell response in relation to viral kinetics and treatment outcome (DITTO-HCV project).

Pilli M, Zerbini A, Penna A, Orlandini A, Lukasiewicz E, Pawlotsky JM, Zeuzem S, Schalm SW, von Wagner M, Germanidis G, Lurie Y, Esteban JI, Haagmans BL, Hezode C, Lagging M, Negro F, Homburger Y, Neumann AU, Ferrari C, Missale G; DITTO-HCV Study Group.

Gastroenterology. 2007 Oct;133(4):1132-43. Epub 2007 Jul 3.

PMID:
17919489
14.

Predicting treatment outcome following 24 weeks peginterferon alpha-2a/ribavirin therapy in patients infected with HCV genotype 1: utility of HCV-RNA at day 0, day 22, day 29, and week 6.

Lukasiewicz E, Hellstrand K, Westin J, Ferrari C, Neumann AU, Pawlotsky JM, Schalm SW, Zeuzem S, Veldt BJ, Hansen BE, Verhey-Hart E, Lagging M.

Hepatology. 2007 Jan;45(1):258-9. No abstract available.

PMID:
17187414
15.

International, multicenter, randomized, controlled study comparing dynamically individualized versus standard treatment in patients with chronic hepatitis C.

Zeuzem S, Pawlotsky JM, Lukasiewicz E, von Wagner M, Goulis I, Lurie Y, Gianfranco E, Vrolijk JM, Esteban JI, Hezode C, Lagging M, Negro F, Soulier A, Verheij-Hart E, Hansen B, Tal R, Ferrari C, Schalm SW, Neumann AU; DITTO-HCV Study Group.

J Hepatol. 2005 Aug;43(2):250-7.

PMID:
16082736
16.

Alcohol intake in relation to body mass index and waist-to-hip ratio: the importance of type of alcoholic beverage.

Lukasiewicz E, Mennen LI, Bertrais S, Arnault N, Preziosi P, Galan P, Hercberg S.

Public Health Nutr. 2005 May;8(3):315-20.

PMID:
15918929
17.

Could measuring of perceived risk among general practitioners have helped anticipate the French BSE crisis?

Setbon M, Fischler C, Lukasiewicz E, Raude J, Flahault A.

Eur J Epidemiol. 2004;19(4):377-81.

PMID:
15180108
18.

Prevalence, risk factors and outcome of hyperlactataemia in HIV-infected patients.

Hocqueloux L, Alberti C, Feugeas JP, Lafaurie M, Lukasiewicz E, Bagnard G, Carel O, Erlich D, Molina JM.

HIV Med. 2003 Jan;4(1):18-23.

PMID:
12534955
19.

[Dermatology in private practice in France in 2000].

Lukasiewicz E, Martel J, Roujeau JC, Flahault A.

Ann Dermatol Venereol. 2002 Nov;129(11):1261-5. French.

PMID:
12514513
20.

[Incidence and management of condylomata acuminata by French general physicians].

Lukasiewicz E, Aractingi S, Flahault A.

Ann Dermatol Venereol. 2002 Aug-Sep;129(8-9):991-6. French.

PMID:
12442095
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk